July 13, 2007 — The US Food and Drug Administration (FDA) has approved first-time generic formulations for paroxetine hydrochloride extended release tablets, 12.5 mg and 25 mg, for the treatment of ...

GlaxoSmithKline has returned its antidepressant Paxil CR to the market, nearly four months after federal officials seized the drug from three factories for failing to meet manufacturing standards. The ...

Jan 23 (Reuters) - Lupin LtdBy Reuters January 23, 20175:48 AM UTCUpdated January 23, 2017 Jan 23 (Reuters) - Lupin Ltd * "Lupin receives FDA approval for generic Paxil CR tablets" ...

Federal officials seized two types of drugs Friday from a Knoxville, Tenn., distribution center of GlaxoSmithKline PLC after the Food and Drug Administration found the drug company failed to meet ...

U.S. officials Friday seized batches of GlaxoSmithKline's diabetes drug Avandamet and controlled-release antidepressant Paxil CR because of concerns over manufacturing quality. The U.S. Food and Drug ...

WASHINGTON — The Food and Drug Administration halted distribution Friday of the popular antidepressant Paxil CR and the diabetes drug Avandamet, citing concerns about manufacturing problems. FDA ...

Officials in the U.S. seized batches of a diabetes drug and an antidepressant medication on Friday because of concerns the drug company didn't meet manufacturing standards. The drugs are Paxil CR, a ...

On March 4, US marshals seized stocks of "Avandamet" (rosiglitazonemaleate/metformin hydrochloride, for type 2 diabetes) and "Paxil CR"(paroxetine hydrochloride controlled release, for depression ...

May 12, 2006 — The US Food and Drug Administration (FDA) and GlaxoSmithKline have warned healthcare professionals regarding the potential increased risk for suicidal behavior associated with use of ...

PITTSBURGH, Oct. 23 -- Mylan Inc. today announced that it and its subsidiary Mylan Pharmaceuticals Inc. have entered into a patent license and settlement agreement with GlaxoSmithKline (GSK) relating ...